Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
出版年份 2020 全文链接
标题
Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-02-13
DOI
10.3389/fcimb.2020.00049
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis
- (2019) Jing Zhou et al. IMMUNITY
- Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells
- (2019) Zhi-Bin Zhao et al. Cellular & Molecular Immunology
- Expression analysis and significance of PD-1, LAG-3 and TIM-3 in human non-small cell lung cancer using spatially-resolved and multiparametric single-cell analysis.
- (2019) Ila J Datar et al. CLINICAL CANCER RESEARCH
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- CD137 (4-1BB) Engagement Fine-Tunes Synergistic IL-15– and IL-21–Driven NK Cell Proliferation
- (2019) Laurent Vidard et al. JOURNAL OF IMMUNOLOGY
- NKG2A is a NK cell exhaustion checkpoint for HCV persistence
- (2019) Chao Zhang et al. Nature Communications
- The mechanism of anti-PD-L1 antibody efficacy against PD-L1 negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector
- (2019) Wenjuan Dong et al. Cancer Discovery
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
- (2019) Beatriz Sanchez-Correa et al. Cancers
- Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming
- (2019) Aimee Merino et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
- (2018) Frank Vari et al. BLOOD
- Canonical TGF-β Signaling Pathway Represses Human NK Cell Metabolism
- (2018) Vanessa Zaiatz-Bittencourt et al. JOURNAL OF IMMUNOLOGY
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Role of PD-1 during effector CD8 T cell differentiation
- (2018) Eunseon Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
- (2018) Nicole A. P. Lieberman et al. Frontiers in Immunology
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells
- (2018) Linda Quatrini et al. NATURE IMMUNOLOGY
- Effect of Aging on NK Cell Population and Their Proliferation at Ex Vivo Culture Condition
- (2018) Sellamuthu Subbanna Gounder et al. Analytical Cellular Pathology
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Human CD96 correlates to NK cell exhaustion and predicts the prognosis of human hepatocellular carcinoma
- (2018) Haoyu Sun et al. HEPATOLOGY
- Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of “senescent” NK cells to lose CD57 expression and start expressing NKG2A
- (2018) Maria A. Streltsova et al. PLoS One
- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
- (2017) Hyungseok Seo et al. Nature Communications
- A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
- (2017) Brent A. Williams et al. Oncotarget
- Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
- (2017) Robert J. Canter et al. Journal for ImmunoTherapy of Cancer
- Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells
- (2016) Dhifaf Sarhan et al. CANCER RESEARCH
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
- (2016) Jesus I. Luna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
- (2016) Asma Beldi-Ferchiou et al. Oncotarget
- Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
- (2016) Lisa L. Liu et al. Cell Reports
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Canine cancer immunotherapy studies: linking mouse and human
- (2016) Jiwon S. Park et al. Journal for ImmunoTherapy of Cancer
- NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
- (2015) Garnet Suck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity
- (2015) Gail D. Sckisel et al. IMMUNITY
- Natural Killer Cell Memory
- (2015) Timothy E. O’Sullivan et al. IMMUNITY
- Mechanisms of human autoimmunity
- (2015) Michael D. Rosenblum et al. JOURNAL OF CLINICAL INVESTIGATION
- NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
- (2015) Erik Ames et al. JOURNAL OF IMMUNOLOGY
- A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
- (2015) W. Deng et al. SCIENCE
- Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion
- (2015) Han-Ching Tseng et al. Oncotarget
- Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review
- (2015) Sandeep Nayar et al. OncoImmunology
- The natural killer cell dysfunction of aged mice is due to the bone marrow stroma and is not restored by IL-15/IL-15Rα treatment
- (2014) Savita Nair et al. AGING CELL
- Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation
- (2014) N. N. Shah et al. BLOOD
- The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
- (2014) Robert J. Johnston et al. CANCER CELL
- Clonal Tracking of Rhesus Macaque Hematopoiesis Highlights a Distinct Lineage Origin for Natural Killer Cells
- (2014) Chuanfeng Wu et al. Cell Stem Cell
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
- (2014) Michele Ardolino et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF- 1
- (2014) H. Li et al. JOURNAL OF IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
- (2014) I. Melero et al. Cancer Discovery
- Out-of-Sequence Signal 3 as a Mechanism for Virus-Induced Immune Suppression of CD8 T Cell Responses
- (2014) Stina L. Urban et al. PLoS Pathogens
- T-bet and Eomes Are Differentially Linked to the Exhausted Phenotype of CD8+ T Cells in HIV Infection
- (2014) Marcus Buggert et al. PLoS Pathogens
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell–Cell Contact and Secreted Factors
- (2014) Han-Ching Tseng et al. Frontiers in Immunology
- The impact of ageing on natural killer cell function and potential consequences for health in older adults
- (2013) Jon Hazeldine et al. AGEING RESEARCH REVIEWS
- NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
- (2013) V. Beziat et al. BLOOD
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Natural killer cell development and maturation in aged mice
- (2013) Eleni Beli et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Utilization of mouse models to decipher natural killer cell biology and potential clinical applications
- (2013) C. M. Sungur et al. Hematology-American Society of Hematology Education Program
- PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
- (2013) A. W. MacFarlane et al. Cancer Immunology Research
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Cytokine activation induces human memory-like NK cells
- (2012) R. Romee et al. BLOOD
- Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation
- (2012) Anjali Mishra et al. CANCER CELL
- Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
- (2012) T. K. Garg et al. HAEMATOLOGICA
- Antigen-Specific IL-2 Secretion Correlates with NK Cell Responses after Immunization of Tanzanian Children with the RTS,S/AS01 Malaria Vaccine
- (2012) A. Horowitz et al. JOURNAL OF IMMUNOLOGY
- Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
- (2012) B. Foley et al. JOURNAL OF IMMUNOLOGY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling
- (2012) S. Rajagopalan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of T Cell Development and Transformation
- (2011) Ute Koch et al. Annual Review of Cell and Developmental Biology
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
- (2011) B. Foley et al. BLOOD
- Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
- (2011) N. Halama et al. CLINICAL CANCER RESEARCH
- Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD
- (2011) Silke Wiesmayr et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells
- (2011) E. Narni-Mancinelli et al. INTERNATIONAL IMMUNOLOGY
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
- (2011) Srinivas S. Somanchi et al. Jove-Journal of Visualized Experiments
- Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy
- (2011) Michael Nowak et al. Cancers
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
- (2010) S. Lopez-Verges et al. BLOOD
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
- (2010) D. M. Benson et al. BLOOD
- Natural Killer Cell Education and Tolerance
- (2010) Mark T. Orr et al. CELL
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Natural killer cells in human autoimmune diseases
- (2010) Nicolas Schleinitz et al. IMMUNOLOGY
- Cross-Talk between T Cells and NK Cells Generates Rapid Effector Responses to Plasmodium falciparum-Infected Erythrocytes
- (2010) A. Horowitz et al. JOURNAL OF IMMUNOLOGY
- NK Cells as Effectors of Acquired Immune Responses: Effector CD4+ T Cell-Dependent Activation of NK Cells Following Vaccination
- (2010) A. Horowitz et al. JOURNAL OF IMMUNOLOGY
- 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection
- (2010) Mark T Orr et al. NATURE IMMUNOLOGY
- T Cell Activation
- (2009) Jennifer E. Smith-Garvin et al. Annual Review of Immunology
- Replicative potential of human natural killer cells
- (2009) Hiroyuki Fujisaki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- Adaptive immune features of natural killer cells
- (2009) Joseph C. Sun et al. NATURE
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Cytokine-induced memory-like natural killer cells
- (2009) Megan A. Cooper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
- (2009) N. Stanietsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
- Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
- (2008) Rafael Carretero et al. IMMUNOGENETICS
- Natural killer cell recognition of missing self
- (2008) Klas Kärre NATURE IMMUNOLOGY
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- Exploring regulatory mechanisms of CD8+ T cell contraction
- (2008) M. Prlic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BH3-only protein Puma contributes to death of antigen-specific T cells during shutdown of an immune response to acute viral infection
- (2008) S. F. Fischer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now